'Huawei of genomics' plots global expansion on COVID windfall

Threat of US sanctions clouds outlook for China's BGI

20210802N BGI genetic testing

A BGI genetic testing laboratory in Kunming: The company looks to parlay global connections forged through the COVID testing labs to expand its genomics business worldwide. © Reuters

TAKASHI KAWAKAMI, Nikkei staff writer

GUANGZHOU -- Just days after Guangzhou reported a surge in coronavirus cases at the end of May, a massive PCR testing lab appeared seemingly out of thin air at a gymnasium in the southern Chinese city.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.